Mammography use among women ages 40-49 after the 2009 U.S. preventive services task force recommendation

Journal of General Internal Medicine

Volumn 28, Issue 11, 2013, Pages 1447-1453

  Block, Lauren D ^a   Jarlenski, Marian P ^b   Wu, Albert W ^a,b   Bennett, Wendy L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

cancer screening; mammography; preventive health; women's health

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; EDUCATIONAL STATUS; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROBABILITY; RACE; UNITED STATES;

ADULT; ADVISORY COMMITTEES; AGED; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH PLANNING GUIDELINES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POPULATION SURVEILLANCE; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 84885948594     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2482-5     Document Type: Article

References (37)

1. US Preventive Services. Task force. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009;151:716-726.
2. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: Systematic evidence review update for the U.S. Preventive Services Task Force. Evidence review update. Rockville: Agency for Healthcare Research and Quality; 2009.
3. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727-37.
4. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Int Med. 2012;156(7):491-9.
5. Partridge AH, Winer EP. On mammography - more agreement than disagreement. N Engl J Med. 2009;361:2499-501.
6. DeAngelis CD, Fontanarosa PB. U.S. preventive services task force and breast cancer screening. JAMA. 2010;303(2):173-4.
7. Squiers LB, Holden DJ, Dolina SE, et al. The public's response to the U.S. preventive services task force's 2009 recommendations on mammography screening. Am J Prev Med. 2010;40(5):497-504.
8. Davidson AS, Liao X, Magee D. Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure. Am J Obstet Gynecol. 2011;205:e1-7.
9. American Cancer Society. American Cancer Society guidelines for the early detection of cancer. www.cancer.org/Healthy/FindCancerEarly/ CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early- detection-of-cancer. Accessed April 21, 2013.
10. Hinz EK, Kudesia R, Rolston R, et al. Physician knowledge of and adherence to the revised breast cancer screening guidelines by the U.S. preventive services. Task Force. Am J Obstet Gynecol. 2011;205:201. e1-5.
11. Miller JW, King JB, Ryerson AB, et al. Mammography use from 2000-6: state-level trends with corresponding breast cancer incidence rates. Am J Roentology. 2009;192:352-60.
12. Ryerson AB, Miller JQ, Eheman CR, et al. Recent trends in U.S. mammography use from 2000-6: a population-based analysis. Prev Med. 2008;47:477-82.
13. Centers for Disease Control and Prevention (CDC). Cancer Screening- United States, 2010. Morbidity and Mortality Weekly Reports. 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6103a1.htm. Accessed May 1, 2013.
14. Meissner HI, Klabunde CN, Han PK, et al. Breast cancer screening beliefs, recommendations, and practices. Cancer. 2011;117:3101-11.
15. Bellizzi KM, Breslau ES, Burness A, et al. Prevalence of cancer screening in older and racially diverse adults. Arch Intern Med. 2011;171(22):2031-37.
16. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer. 2013. doi: 10.1002/cncr.28105.
17. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006, 2008, and 2010.
18. Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001;46:S03-S42.
19. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women's self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12:1182.
20. Behavioral Risk Factor Surveillance Survey. 2011 survey data information: Comparability of data. CDC. 2011. http://www.cdc.gov/brfss/annual-data/annual- 2011.htm. Accessed April 21, 2013.
21. Lambrew JM, Defriese GH, Carey TS, Ricketts TC, Biddle AK. The effects of having a regular doctor on access to primary care. Med Care. 1996;34(2):138-51.
22. Shoen C, DesRoches C. Uninsured and unstably insured: the importance of continuous insurance coverage. Health Serv Res. 2000;35(1):187-203.
23. Bertrand M, Duflo E, Mullainathan S. How much should we trust difference-in-differences estimates? Q J Econ. 2004;119(1):249-75.
24. Norton EC, Wang H, Ai C. Computing interaction effects and standard errors in logit and probit models. Stata J. 2004;4(2):154-67.
25. Volpp KG, Rosen AK, Rosenbaum PR, et al. Mortality among medicare beneficiaries in the first two years following ACGME resident duty hour reform. JAMA. 2007;298(9):975-83.
26. Karaca-Mandic P, Norton EC, Dowd B. Interaction terms in nonlinear models. Health Serv Res. 2012;47(1):255-274.
27. Centers for Disease Control and Prevention (CDC). BRFSS Weighting Formula. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. http://www.cdc.gov/brfss/annual-data/2010/ 2010-weighting.htm. Accessed April 21, 2013.
28. Nutting PA, Baier M, Werner JJ, Cutter G, Conry C, Stewart L. Competing demands in the office visit: what influences mammography recommendations. J Am Board Fam Pract. 2001;14:352-61.
29. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, United States, 1989-2005. Vaccine. 2008;26(14):1786-93.
30. Smith RA, Cokkinides V, Brookes D, Saslow D, Brawley OW. Cancer screening in the United States, 2010: a review of current American cancer society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99-119.
31. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev. 2006;15(2):389-94.
32. Zelaidt SB, Hoffman RM, Etzioni R, et al. Influence of publication of US and European prostate cancer screening trials on PSA testing practices. J Natl Cancer Inst. 2011;103:520-3.
33. Feldman S. Making sense of the new cervical cancer screening guidelines. N Engl J Med. 2011;365:2145-47.
34. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57(2):105-11.
35. Rauscher GH, Johnson TP, Cho YI, et al. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748-57.
36. Craig BM, Quinn GP, Vadaparampil ST. Sensitivity of self-report mammography use in older women. Am J Prev Med. 2009;37(5):441-4.
37. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089-96.